These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15561953)
1. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Lamharzi N; Renard CB; Kramer F; Pennathur S; Heinecke JW; Chait A; Bornfeldt KE Diabetes; 2004 Dec; 53(12):3217-25. PubMed ID: 15561953 [TBL] [Abstract][Full Text] [Related]
2. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D Diabetes; 2000 Jun; 49(6):1064-9. PubMed ID: 10866061 [TBL] [Abstract][Full Text] [Related]
3. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Boullier A; Li Y; Quehenberger O; Palinski W; Tabas I; Witztum JL; Miller YI Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1169-76. PubMed ID: 16484596 [TBL] [Abstract][Full Text] [Related]
4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
5. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation. Babaei S; Picard P; Ravandi A; Monge JC; Lee TC; Cernacek P; Stewart DJ Cardiovasc Res; 2000 Oct; 48(1):158-67. PubMed ID: 11033118 [TBL] [Abstract][Full Text] [Related]
6. Macrophage proliferation in atherosclerosis. Sakai M; Kobori S; Miyazaki A; Horiuchi S Curr Opin Lipidol; 2000 Oct; 11(5):503-9. PubMed ID: 11048893 [TBL] [Abstract][Full Text] [Related]
7. Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice. Khan-Merchant N; Penumetcha M; Meilhac O; Parthasarathy S J Nutr; 2002 Nov; 132(11):3256-62. PubMed ID: 12421837 [TBL] [Abstract][Full Text] [Related]
8. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis. Wu L; Vikramadithyan R; Yu S; Pau C; Hu Y; Goldberg IJ; Dansky HM J Lipid Res; 2006 Oct; 47(10):2215-22. PubMed ID: 16840797 [TBL] [Abstract][Full Text] [Related]
9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499 [TBL] [Abstract][Full Text] [Related]
10. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403 [TBL] [Abstract][Full Text] [Related]
11. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597 [TBL] [Abstract][Full Text] [Related]
12. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice. Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276 [TBL] [Abstract][Full Text] [Related]
13. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153 [TBL] [Abstract][Full Text] [Related]
14. Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1). Hamilton JA; Byrne R; Jessup W; Kanagasundaram V; Whitty G Biochem J; 2001 Feb; 354(Pt 1):179-87. PubMed ID: 11171093 [TBL] [Abstract][Full Text] [Related]
15. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138 [TBL] [Abstract][Full Text] [Related]
17. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Kanter JE; Johansson F; LeBoeuf RC; Bornfeldt KE Circ Res; 2007 Mar; 100(6):769-81. PubMed ID: 17395883 [TBL] [Abstract][Full Text] [Related]